{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:00:02Z","timestamp":1776459602850,"version":"3.51.2"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":1274,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 HL111054"],"award-info":[{"award-number":["U01 HL111054"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL115207"],"award-info":[{"award-number":["R01 HL115207"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1074\/jbc.m116.765727","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T01:40:38Z","timestamp":1485308438000},"page":"3888-3899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Selective Ablation of Tumor Suppressors in Parafollicular C Cells Elicits Medullary Thyroid Carcinoma"],"prefix":"10.1016","volume":"292","author":[{"given":"Hai","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuwen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingzhe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pao-Tien","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M116.765727_bib1","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/S0140-6736(16)30172-6","article-title":"Thyroid cancer","volume":"388","author":"Cabanillas","year":"2016","journal-title":"Lancet"},{"key":"10.1074\/jbc.M116.765727_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12022-013-9287-2","article-title":"Medullary thyroid carcinoma: a 25-year perspective","volume":"25","author":"Matias-Guiu","year":"2014","journal-title":"Endocr. Pathol"},{"key":"10.1074\/jbc.M116.765727_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/CCO.0b013e328351c71a","article-title":"Recent advances in the molecular pathogenesis and targeted therapies of medullary thyroid carcinoma","volume":"24","author":"Almeida","year":"2012","journal-title":"Curr. Opin. Oncol"},{"key":"10.1074\/jbc.M116.765727_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1074\/jbc.M116.765727_bib5","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1002\/cncr.28858","article-title":"Medical management of metastatic medullary thyroid cancer","volume":"120","author":"Maxwell","year":"2014","journal-title":"Cancer"},{"key":"10.1074\/jbc.M116.765727_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ctrv.2016.09.006","article-title":"Systemic treatment and management approaches for medullary thyroid cancer","volume":"50","author":"Ernani","year":"2016","journal-title":"Cancer Treat. Rev"},{"key":"10.1074\/jbc.M116.765727_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrendo.2015.217","article-title":"Thyroid cancer in 2015: molecular landscape of thyroid cancer continues to be deciphered","volume":"12","author":"Nikiforov","year":"2016","journal-title":"Nat. Rev. Endocrinol"},{"key":"10.1074\/jbc.M116.765727_bib8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc3431","article-title":"Molecular pathogenesis and mechanisms of thyroid cancer","volume":"13","author":"Xing","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.M116.765727_bib9","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1080\/17512433.2016.1204230","article-title":"Targeted therapies in thyroid cancer: an extensive review of the literature","volume":"9","author":"Bikas","year":"2016","journal-title":"Exp. Rev. Clin. Pharmacol"},{"key":"10.1074\/jbc.M116.765727_bib10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.trecan.2016.09.001","article-title":"The emerging role of Cdk5 in cancer","volume":"2","author":"Pozo","year":"2016","journal-title":"Trends Cancer"},{"key":"10.1074\/jbc.M116.765727_bib11","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/cncr.28661","article-title":"RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma","volume":"120","author":"Krampitz","year":"2014","journal-title":"Cancer"},{"key":"10.1074\/jbc.M116.765727_bib12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","article-title":"Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC","volume":"2","author":"Donis-Keller","year":"1993","journal-title":"Hum. Mol. Genet"},{"key":"10.1074\/jbc.M116.765727_bib13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"363","author":"Mulligan","year":"1993","journal-title":"Nature"},{"key":"10.1074\/jbc.M116.765727_bib14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrendo.2016.11","article-title":"A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma","volume":"12","author":"Romei","year":"2016","journal-title":"Nat. Rev. Endocrinol"},{"key":"10.1074\/jbc.M116.765727_bib15","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1210\/jc.2007-1005","article-title":"RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center","volume":"92","author":"Elisei","year":"2007","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1074\/jbc.M116.765727_bib16","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1158\/0008-5472.CAN-05-2699","article-title":"Inactivation of conditional Rb by Villin-Cre leads to aggressive tumors outside the gastrointestinal tract","volume":"66","author":"Kucherlapati","year":"2006","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M116.765727_bib17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/onc.2013.589","article-title":"p53 suppresses carcinoma progression by inhibiting mTOR pathway activation","volume":"34","author":"Akeno","year":"2015","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M116.765727_bib18","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/sj.onc.1202381","article-title":"RET cooperates with RB\/p53 inactivation in a somatic multi-step model for murine thyroid cancer","volume":"17","author":"Coxon","year":"1998","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M116.765727_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000447333","article-title":"On the origin of cells and derivation of thyroid cancer: C cell story revisited","volume":"5","author":"Nilsson","year":"2016","journal-title":"Eur. Thyroid J"},{"key":"10.1074\/jbc.M116.765727_bib20","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1073\/pnas.94.7.3330","article-title":"Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation","volume":"94","author":"Michiels","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M116.765727_bib21","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/ERC-16-0399","article-title":"Animal models of medullary thyroid cancer: state of the art and view to the future","volume":"24","author":"Vitale","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1074\/jbc.M116.765727_bib22","doi-asserted-by":"crossref","first-page":"17531","DOI":"10.1073\/pnas.1207238109","article-title":"Functional characterization of pulmonary neuroendocrine cells in lung development, injury, and tumorigenesis","volume":"109","author":"Song","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M116.765727_bib23","doi-asserted-by":"crossref","first-page":"e18472","DOI":"10.1371\/journal.pone.0018472","article-title":"Ascl1 (Mash1) defines cells with long-term neurogenic potential in subgranular and subventricular zones in adult mouse brain","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M116.765727_bib24","series-title":"Manipulating the Mouse Embryo: A Laboratory Manual","author":"Nagy","year":"2003"},{"key":"10.1074\/jbc.M116.765727_bib25","series-title":"Gene targeting: a practical approach","author":"Joyner","year":"2000"},{"key":"10.1074\/jbc.M116.765727_bib26","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0960-9822(07)00562-3","article-title":"Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase","volume":"8","author":"Danielian","year":"1998","journal-title":"Curr. Biol"},{"key":"10.1074\/jbc.M116.765727_bib27","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/dvg.20335","article-title":"A global double-fluorescent Cre reporter mouse","volume":"45","author":"Muzumdar","year":"2007","journal-title":"Genesis"},{"key":"10.1074\/jbc.M116.765727_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/5007","article-title":"Generalized lacZ expression with the ROSA26 Cre reporter strain","volume":"21","author":"Soriano","year":"1999","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.M116.765727_bib29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/ng0894-480","article-title":"Cooperative tumorigenic effects of germline mutations in Rb and p53","volume":"7","author":"Williams","year":"1994","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.M116.765727_bib30","first-page":"1146","article-title":"Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin","volume":"55","author":"Harvey","year":"1995","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M116.765727_bib31","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1101\/gad.14.8.994","article-title":"Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum","volume":"14","author":"Marino","year":"2000","journal-title":"Genes Dev"},{"key":"10.1074\/jbc.M116.765727_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1677\/JME-09-0024","article-title":"Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets","volume":"43","author":"Cerrato","year":"2009","journal-title":"J. Mol. Endocrinol"},{"key":"10.1074\/jbc.M116.765727_bib33","first-page":"188","article-title":"The PI3K\/Akt pathway in tumors of endocrine tissues","volume":"6","author":"Robbins","year":"2015","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1074\/jbc.M116.765727_bib34","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1126\/science.1065518","article-title":"Negative regulation of neural stem\/progenitor cell proliferation by the Pten tumor suppressor gene in vivo","volume":"294","author":"Groszer","year":"2001","journal-title":"Science"},{"key":"10.1074\/jbc.M116.765727_bib35","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.18632\/oncotarget.380","article-title":"Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors","volume":"2","author":"Antico Arciuch","year":"2011","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.M116.765727_bib36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12672-014-0208-8","article-title":"Modeling anaplastic thyroid carcinoma in the mouse","volume":"6","author":"Champa","year":"2015","journal-title":"Hormones Cancer"},{"key":"10.1074\/jbc.M116.765727_bib37","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1530\/ERC-15-0555","article-title":"Treatment of advanced thyroid cancer with targeted therapies: ten years of experience","volume":"23","author":"Viola","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1074\/jbc.M116.765727_bib38","doi-asserted-by":"crossref","first-page":"R287","DOI":"10.1530\/ERC-16-0104","article-title":"New drugs for medullary thyroid cancer: new promises?","volume":"23","author":"Spitzweg","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1074\/jbc.M116.765727_bib39","doi-asserted-by":"crossref","first-page":"26814","DOI":"10.18632\/oncotarget.4254","article-title":"A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives","volume":"6","author":"Russo","year":"2015","journal-title":"Oncotarget"},{"key":"10.1074\/jbc.M116.765727_bib40","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ajpath.2012.10.025","article-title":"Differential gene expression of medullary thyroid carcinoma reveals specific markers associated with genetic conditions","volume":"182","author":"Maliszewska","year":"2013","journal-title":"Am. J. Pathol"},{"key":"10.1074\/jbc.M116.765727_bib41","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ccr.2013.08.027","article-title":"The role of Cdk5 in neuroendocrine thyroid cancer","volume":"24","author":"Pozo","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1074\/jbc.M116.765727_bib42","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fendo.2012.00031","article-title":"Role of the wnt pathway in thyroid cancer","volume":"3","author":"Sastre-Perona","year":"2012","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1074\/jbc.M116.765727_bib43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jss.2011.03.035","article-title":"Expression of the active Notch1 decreases MTC tumor growth in vivo","volume":"171","author":"Jaskula-Sztul","year":"2011","journal-title":"J. Surg. Res"},{"key":"10.1074\/jbc.M116.765727_bib44","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/cncr.27742","article-title":"Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo","volume":"119","author":"Yu","year":"2013","journal-title":"Cancer"},{"key":"10.1074\/jbc.M116.765727_bib45","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1158\/0008-5472.CAN-07-6052","article-title":"A novel RET kinase-\u03b2-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma","volume":"68","author":"Gujral","year":"2008","journal-title":"Cancer Res"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582034895X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582034895X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M116.765727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T06:38:23Z","timestamp":1641278303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192582034895X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S002192582034895X"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m116.765727","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective Ablation of Tumor Suppressors in Parafollicular C Cells Elicits Medullary Thyroid Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M116.765727","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}